Login
Companies $SGP
$31.67 -$1.21 (3.68%) Live
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc.

spyglasspharma.com

What Do They Do?

Develops sustained-release eye implants for cataract surgeons treating patients with glaucoma or ocular hypertension.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −147% (Loss)
vs −$9.8M in Q3 FY2025
  • Oct 1, 2026 Acquired its intraocular lens supplier Advanced Vision Science had been SpyGlass's intraocular lens supplier; the purchase price was based on $13,000,000, subject to adjustments.

Who Do They Compete With?

Competes with Alcon, Allergan, AbbVie, Bausch & Lomb, Glaukos, Johnson & Johnson, Astellas, Genentech, Roche, and Regeneron

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support